(H032) “Rule Out Myeloid Malignancy”: Evaluation of Molecular Testing Utility for Suspected Myeloid Malignancies. A Single Institution's Experience.

Friday, November 17, 2023

9:15 AM – 10:15 AM MST

Speaker(s)

Moyosore Awobajo, MD, MSc (she/her/hers)

AP/CP Resident, PGY-4
University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States